Cargando…
Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke
OBJECTIVE: At present, the absence of a pharmacological neuroprotectant represents an important unmet clinical need in the treatment of ischemic and traumatic brain injury. Recent evidence suggests that administration of apolipoprotein E mimetic therapies represent a viable therapeutic strategy in t...
Autores principales: | Tu, Tian Ming, Kolls, Brad J., Soderblom, Erik J., Cantillana, Viviana, Ferrell, Paul Durham, Moseley, M. Arthur, Wang, Haichen, Dawson, Hana N., Laskowitz, Daniel T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376751/ https://www.ncbi.nlm.nih.gov/pubmed/28382306 http://dx.doi.org/10.1002/acn3.399 |
Ejemplares similares
-
Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH
por: Liu, Ji, et al.
Publicado: (2018) -
Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model
por: Laskowitz, Daniel T., et al.
Publicado: (2017) -
Antagonism of nicotinic acetycholinergic receptors by CN‐105, an apoE‐mimetic peptide reduces stroke‐induced excitotoxicity
por: Xue, Miaomiao, et al.
Publicado: (2022) -
Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage
por: Lei, Beilei, et al.
Publicado: (2016) -
Erratum: Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage
por: Lei, Beilei, et al.
Publicado: (2017)